Posaconazole

Prevention of Fungal Infections

Posaconazole is frequently prescribed to prevent invasive fungal infections in people who are at high risk due to a severely weakened immune system. This includes:

• Patients undergoing chemotherapy for certain types of cancer, such as leukemia, who have low white blood cell counts (neutropenia).
• People who have received a hematopoietic stem cell transplant and are experiencing graft-versus-host disease.

Treatment of Specific Infections

This medication is also used to treat active fungal infections, including:

• Oropharyngeal candidiasis: A yeast infection of the mouth and throat, also known as thrush.
• Invasive aspergillosis: A serious infection caused by a specific type of mold that can affect the lungs and spread to other parts of the body.

In some cases, posaconazole may be used to treat other rare or serious fungal infections, such as fusariosis or chromoblastomycosis, especially when other antifungal treatments have not been effective or cannot be tolerated.

Mechanism of Action

Posaconazole belongs to a class of medications known as triazole antifungals. It works by interfering with the way fungi build their cell membranes, which are the protective outer layers of the fungal cells.

To grow and survive, fungi must produce a specific substance called ergosterol. This substance is essential for maintaining the structure and integrity of the fungal cell membrane. Posaconazole blocks the production of ergosterol, which leads to several effects on the fungus:

• The fungal cell membrane becomes weak and develops holes.
• Essential components inside the fungal cell begin to leak out.
• The fungus is unable to grow, reproduce, or spread throughout the body.

By preventing the fungi from multiplying, posaconazole helps the body's immune system to clear the infection. It is used both to treat active fungal infections and to prevent infections in people who have a high risk of developing them due to a weakened immune system.

Common Side Effects

• Nausea and vomiting
• Diarrhea or constipation
• Stomach pain
• Headache
• Fever or chills
• Cough
• Dizziness
• Feeling tired or weak
• Swelling in the hands, ankles, or feet
• Rash or itching
• Changes in taste

Serious Side Effects

Seek medical attention immediately if you notice any of the following serious symptoms:

• Liver problems: Symptoms include yellowing of the skin or eyes, dark urine, pale stools, or severe pain in the upper right stomach area.
• Heart rhythm changes: Fast, pounding, or irregular heartbeat, or feeling like you might pass out.
• Low potassium levels: Signs include muscle weakness, leg cramps, or a tingling sensation.
• Adrenal gland issues: Severe fatigue, dizziness, or muscle weakness.
• Severe skin reactions: Blistering, peeling, or a red skin rash.
• Allergic reactions: Hives, swelling of the face or throat, and difficulty breathing.

Liver Health

Severe liver reactions, including hepatitis and liver failure, have occurred in patients taking posaconazole. Liver function tests are typically performed at the start of therapy and periodically thereafter. Treatment may be stopped if liver enzyme levels become significantly elevated.

Heart Rhythm Risks

Posaconazole may cause a condition called QT prolongation, which affects the heart rhythm. This can lead to serious heart rhythm disorders. The risk is increased for individuals with pre-existing heart conditions or those with uncorrected electrolyte imbalances, such as low potassium, magnesium, or calcium.

Drug Interactions

This medication can significantly increase the levels of other drugs in the body. It is generally not used with:

• Certain cholesterol medications (statins) like simvastatin or lovastatin.
• Ergot alkaloids.
• Pimozide or quinidine.
• Sirolimus.

Kidney Considerations

The intravenous formulation contains an ingredient that may accumulate in patients with moderate to severe kidney impairment. In these cases, oral formulations are often preferred.

Pregnancy and Breastfeeding

Posaconazole may cause fetal harm when administered to pregnant women. It is generally advised that the drug only be used during pregnancy if the potential benefit justifies the potential risk to the fetus. It is not known if the drug passes into human breast milk.

Pregnancy

There are no adequate and well-controlled studies of posaconazole use in pregnant women. In animal studies, the medication was shown to cause skeletal malformations and other developmental issues when administered at doses lower than those typically used in humans. Because of these findings, posaconazole should be used during pregnancy only if the potential benefit to the mother justifies the potential risk to the fetus.

Individuals who are pregnant or planning to become pregnant should discuss the risks and benefits of this treatment with their healthcare provider. Women of childbearing potential may be advised to use effective contraception during treatment.

Breastfeeding

It is not known whether posaconazole is excreted in human breast milk. Because many drugs are present in human milk and there is a potential for serious adverse reactions in nursing infants, a decision must be made whether to discontinue breastfeeding or to discontinue the drug. This decision should take into account the importance of the medication to the mother's health and should be discussed thoroughly with a healthcare professional.

Available Forms

Posaconazole is provided in the following forms:

• Delayed-release tablets: These tablets are designed to be swallowed whole and should not be crushed, chewed, or broken.
• Oral suspension: A liquid form of the medication typically taken by mouth.
• Delayed-release oral suspension: A powder that must be mixed with water to create a liquid suspension before administration.
• Injection: A solution intended for intravenous infusion, usually administered by a healthcare professional in a clinical setting.

The different oral forms, such as the tablets and the liquid suspension, are not interchangeable because the body absorbs them differently. Patients should only use the specific form and instructions provided by their healthcare provider.

FDA Approval and Indications

Posaconazole is approved by the U.S. Food and Drug Administration (FDA) for the following indications:

• Prophylaxis: Prevention of invasive Aspergillus and Candida infections in patients 13 years of age and older who are at high risk due to being severely immunocompromised, such as those with hematologic malignancies or graft-versus-host disease.
• Treatment: Treatment of oropharyngeal candidiasis (thrush), including cases that have not responded to other antifungal therapies.

Safety Communications and Medication Errors

The FDA has issued safety communications regarding the risk of medication errors with posaconazole. These warnings focus on the fact that the oral suspension and the delayed-release tablets are not interchangeable on a milligram-to-milligram basis. Because the body absorbs these two forms differently, substituting one for the other without a specific dosage adjustment by a healthcare provider can lead to drug levels that are either too low to be effective or high enough to cause toxicity.

Regulatory Status

Posaconazole is a prescription-only medication. It is available in several formulations, including delayed-release tablets, an oral suspension, and an intravenous injection. While it does not have a boxed warning, the FDA requires labeling to include precautions regarding potential liver toxicity and effects on the heart's electrical activity (QT prolongation).

Factors Influencing Cost

Several factors determine the final price of posaconazole treatment:

• Drug Formulation: Posaconazole is available as delayed-release tablets, an oral suspension, and an intravenous (IV) injection. The cost typically differs between these delivery methods.
• Generic vs. Brand Name: Generic versions of posaconazole tablets and oral suspension are available. Generic medications are generally more affordable than their brand-name counterparts.
• Insurance Coverage: Most prescription drug plans provide coverage for posaconazole, but the out-of-pocket expense depends on your specific plan's deductible, copay, or coinsurance levels.
• Pharmacy Selection: Prices can vary between different retail pharmacies, mail-order services, and specialty pharmacies.

If you have difficulty affording your medication, you may want to ask your healthcare provider or pharmacist about patient assistance programs or manufacturer savings cards that may be available for certain formulations. It is also helpful to check if your insurance requires prior authorization before they will cover the cost of this antifungal medication.